Dr Robert M Zielinski, MD | |
295 Essjay Rd, Williamsville, NY 14221-8216 | |
(716) 630-1059 | |
(716) 630-1028 |
Full Name | Dr Robert M Zielinski |
---|---|
Gender | Male |
Speciality | Hematology |
Experience | 39 Years |
Location | 295 Essjay Rd, Williamsville, New York |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1043260664 | NPI | - | NPPES |
040426001784 | Other | NY | FIDELIS |
0021748 | Other | NY | GHI |
01209778 | Medicaid | NY | |
161000580 | Other | NY | EMPIRE |
00010194201 | Other | NY | UNIVERA |
110114167 | Other | NY | RR MEDICARE |
168200-4W | Other | NY | WORKERS COMPENSATION |
2403614 | Other | NY | IHA |
000510922007 | Other | NY | HEALTH NOW |
161000580 | Other | NY | NOVA |
161000580 | Other | NY | NORTH AMERICAN PREFERRED |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RH0003X | Internal Medicine - Hematology & Oncology | 168200-1 (New York) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Medina Memorial Hospital | Medina, NY | Hospital |
Kaleida Health | Buffalo, NY | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Buffalo Medical Group, P.c. | 7012820301 | 230 |
News Archive
Exelixis, Inc. today announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute's Cancer Therapy Evaluation Program (CTEP) for further evaluation of cabozantinib, Exelixis' lead compound, in a variety of solid tumors.
A recent study by a Saint Louis University researcher confirms findings that about half of the U.S. population has a version of a gene that causes them to metabolize food differently, putting them at greater risk of developing diabetes.
Five years of high-intensity interval training increased quality of life, improved fitness and might very well have extended the lives of participants in the Generation 100 study.
Reduced off-medication connectivity in the basal ganglia network separates patients with early Parkinson's disease from healthy controls with high accuracy, preliminary findings suggest.
CDC has released new data on the safety of the COVID-19 vaccines in pregnant people and is recommending all people 12 years of age and older get vaccinated against COVID-19.
› Verified 3 days ago
Entity Name | Kaleida Health |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1366473183 PECOS PAC ID: 7810805280 Enrollment ID: O20031105000212 |
News Archive
Exelixis, Inc. today announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute's Cancer Therapy Evaluation Program (CTEP) for further evaluation of cabozantinib, Exelixis' lead compound, in a variety of solid tumors.
A recent study by a Saint Louis University researcher confirms findings that about half of the U.S. population has a version of a gene that causes them to metabolize food differently, putting them at greater risk of developing diabetes.
Five years of high-intensity interval training increased quality of life, improved fitness and might very well have extended the lives of participants in the Generation 100 study.
Reduced off-medication connectivity in the basal ganglia network separates patients with early Parkinson's disease from healthy controls with high accuracy, preliminary findings suggest.
CDC has released new data on the safety of the COVID-19 vaccines in pregnant people and is recommending all people 12 years of age and older get vaccinated against COVID-19.
› Verified 3 days ago
Entity Name | Buffalo Medical Group, P.c. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1881659506 PECOS PAC ID: 7012820301 Enrollment ID: O20031112000213 |
News Archive
Exelixis, Inc. today announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute's Cancer Therapy Evaluation Program (CTEP) for further evaluation of cabozantinib, Exelixis' lead compound, in a variety of solid tumors.
A recent study by a Saint Louis University researcher confirms findings that about half of the U.S. population has a version of a gene that causes them to metabolize food differently, putting them at greater risk of developing diabetes.
Five years of high-intensity interval training increased quality of life, improved fitness and might very well have extended the lives of participants in the Generation 100 study.
Reduced off-medication connectivity in the basal ganglia network separates patients with early Parkinson's disease from healthy controls with high accuracy, preliminary findings suggest.
CDC has released new data on the safety of the COVID-19 vaccines in pregnant people and is recommending all people 12 years of age and older get vaccinated against COVID-19.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Robert M Zielinski, MD 425 Essjay Rd Ste 170, Williamsville, NY 14221-5782 Ph: (716) 630-1219 | Dr Robert M Zielinski, MD 295 Essjay Rd, Williamsville, NY 14221-8216 Ph: (716) 630-1059 |
News Archive
Exelixis, Inc. today announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute's Cancer Therapy Evaluation Program (CTEP) for further evaluation of cabozantinib, Exelixis' lead compound, in a variety of solid tumors.
A recent study by a Saint Louis University researcher confirms findings that about half of the U.S. population has a version of a gene that causes them to metabolize food differently, putting them at greater risk of developing diabetes.
Five years of high-intensity interval training increased quality of life, improved fitness and might very well have extended the lives of participants in the Generation 100 study.
Reduced off-medication connectivity in the basal ganglia network separates patients with early Parkinson's disease from healthy controls with high accuracy, preliminary findings suggest.
CDC has released new data on the safety of the COVID-19 vaccines in pregnant people and is recommending all people 12 years of age and older get vaccinated against COVID-19.
› Verified 3 days ago
Maria Kontos, DO Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 325 Essjay Rd, Williamsville, NY 14221 Phone: 716-656-4463 | |
Dr. Anderson Ka Ho Lai, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1540 Maple Rd, Williamsville, NY 14221 Phone: 716-568-3514 | |
Colleen Klos, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1540 Maple Rd, Williamsville, NY 14221 Phone: 716-568-3514 | |
Dawn Patricia Hrab, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1835 Maple Rd, Williamsville, NY 14221 Phone: 716-634-5410 Fax: 716-634-0430 | |
Cheri A Gorski-suhr, RPAC Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 825 Wehrle Drive, Cardiology Group Of Western New York,pc, Williamsville, NY 14221 Phone: 716-634-3243 Fax: 716-634-1930 | |
Yijun Cheng, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 295 Essjay Rd, Williamsville, NY 14221 Phone: 716-630-1048 | |
Mr. Martin Neal Mango, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1825 Maple Rd, Williamsville, NY 14221 Phone: 716-631-0834 Fax: 716-631-0880 |